Coagulation disorder in COVID-19

Affiliations

Comment

Thomas Kander. Lancet Haematol. 2020 Sep.

. 2020 Sep;7(9):e630-e632.

doi: 10.1016/S2352-3026(20)30218-0. Epub 2020 Jul 10.

¹ Department of Clinical Sciences, Medical Faculty, Lund University, 221 00 Lund, Sweden. Electronic address: thomas.kander@med.lu.se.

No abstract available

Figures

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, Wang Y, Tang L, Deng J, Mei H, Hu Y. Liao D, et al. Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10. Lancet Haematol. 2020. PMID: 32659214 Free PMC article.

1. Singer M, Deutschman CS, Seymour CW. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315:801–810. - PMC - PubMed
1. Lu R, Zhao X, Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. - PMC - PubMed
1. National Health Commission & National Administration of Traditional Chinese Medicine Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) Chin Med J. 2020;133:1087–1095. - PMC - PubMed
1. Mehta P, McAuley DF, Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. - PMC - PubMed
1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed